Ardent Health provides preliminary 2025 guidance; CMS approves NM directed payment program

Ardent Health, Inc.

CMS approved New Mexico directed payment program for July-December 2024; material Q4 financial benefit expected, amount not yet disclosed.
Preliminary 2025 guidance: revenue growth mid-single digits plus ~$200M from NM and OK programs; adj. EBITDA mid-single digits plus ~$140M incremental.
CEO Martin Bonick new base salary $1,076,000; CFO Alfred Lumsdaine base salary $628,000 under amended employment agreements effective Jan 10, 2025.
CEO severance: 2x (salary + target bonus) for non-CIC, 3x for CIC; CFO severance: 1.5x non-CIC, 2x for CIC.
Management reiterates intent to provide formal 2025 guidance in February 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.